Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Targeted therapies in medical oncology: successes, failures and next steps:

Targeted therapies in medical oncology: successes, failures and next steps: 467829 TAM511758834012467829Therapeutic Advances in Medical OncologyG Mallarkey and RC Coombes Therapeutic Advances in Medical Oncology Editorial Ther Adv Med Oncol Targeted therapies in medical oncology: (2013) 5(1) 5 –16 DOI: 10.1177/ successes, failures and next steps 1758834012467829 © The Author(s), 2012. Reprints and permissions: Gordon Mallarkey and R. Charles Coombes http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: The move towards personalized medicine is France) have tested the entire genome of individ- Gordon Mallarkey, ongoing with exciting research being conducted ual breast cancers in an attempt to better personal- PhD, MRPharmS Sage Publications Ltd, 1 across all areas of oncology. The evidence pre- ize treatment. It may be that whole-genome testing Oliver’s Yard, 55 City Road, sented at the 2012 European Society of Medical can identify both frequent and rare unexpected London, EC1Y 1SP, UK mallarkey@sagepub.co.uk Oncology Congress (Vienna, 28 September–2 genomic events, quantify genomic instability, and Prof. R. Charles Coombes October 2012) adds to the move towards select- detect the driver mutations causing genomic alter- Division of Cancer, ing patients for specific drug treatments based on ations that lead to resistance to targeted agents. Imperial College, Hammersmith Hospital elucidating biomarkers that reveal susceptible Campus, London, UK mutations or pathways. Epidermal growth factor http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Therapeutic Advances in Medical Oncology SAGE

Targeted therapies in medical oncology: successes, failures and next steps:

Loading next page...
 
/lp/sage/targeted-therapies-in-medical-oncology-successes-failures-and-next-Mkkou5QmA9

References (35)

  • G. Fountzilas, H. Gogas, N. Pavlidis, A. Eleftheraki, D. Skarlos, A. Koutras, E. Timotheadou, C. Papandreou, D. Pectasides, M. Dimopoulos (2012)

    Dose-Dense Sequential Adjuvant Chemotherapy With Epirubicin, Paclitaxel and CMF Versus Epirubicin, Cmf and Weekly Docetaxel or Paclitaxel Followed by Trastuzumab for One Year in Patients With Early Breast Cancer

    Annals of Oncology, 23

  • A. Goldhirsch, M. Piccart, M. Procter, E. Azambuja, H. Weber, M. Untch, I. Smith, L. Gianni, C. Jackisch, D. Cameron, R. Bell, M. Dowsett, R. Gelber, B. Leyland-Jones, J. Baselga (2012)

    Hera Trial: 2 Years Versus 1 Year of Trastuzumab After Adjuvant Chemotherapy in Women with Her2-Positive Early Breast Cancer at 8 Years of Median Follow up

    Annals of Oncology, 23

  • J. Taieb, T. Maughan, C. Bokemeyer, E. Cutsem, T. Brodowicz, G. Folprecht, R. Esser, M. Schlichting, J. Tabernero (2012)

    CETUXIMAB COMBINED WITH INFUSIONAL 5-FLUOROURACIL/FOLINIC ACID AND OXALIPLATIN IN METASTATIC COLORECTAL CANCER: POOLED ANALYSIS OF COIN AND OPUS STUDY DATA

    Annals of Oncology, 23

  • G. Masi, F. Loupakis, L. Salvatore, C. Cremolini, L. Fornaro, M. Schirripa, E. Fea, C. Granetto, L. Antonuzzo, E. Giommoni, G. Allegrini, S. Cupini, C. Boni, M. Banzi, S. Chiara, C. Sonaglio, C. Valsuani, A. Bonetti, L. Boni, A. Falcone (2012)

    A Randomized Phase III Study Evaluating the Continuation of Bevacizumab (BV) Beyond Progression in Metastatic Colorectal Cancer (MCRC) Patients (PTS) Who Received BV as Part of First-Line Treatment: Results of the Bebyp Trial by the Gruppo Oncologico Nord Ovest (GONO)

    Annals of Oncology, 23

  • F. André, T. Bachelot, M. Campone, M. Ballester, F. Commo, A. Gonçalves, C. Lévy, J. Ferrero, L. Lacroix, V. Diéras, F. Dalenc, D. Gentien, M. Lacroix, Qing Wang, J. Adélaide, M. Jimenez, H. Bonnefoi (2012)

    Array CGH and DNA Sequencing to Personalize Therapy for Metastatic Breast Cancer: A Prospective National Trial (UNICANCER SAFIR-01)

    Annals of Oncology, 23

  • D. Arnold, H. Schmoll, J. Riera-Knorrenschild, F. Mayer, H. Kroening, W. Scheithauer, D. Nitsche, M. Tschaika, M. Schmidt, B. Wittig, T. Price, K. Wilson, R. Simes, D. Yip, C. Karapetis, N. Tebbutt, V. Gebski, M. Fournier, D. Ferry, D. Ransom, R. Salazar, E. Mini, G. Folprecht, F. Subtil, J. Laethem, J. Thaler, J. Bridgewater, E. Cutsem, C. Lepage, J. Taieb, S. Venderbosch, T. Haan, D. Heideman, T. Maughan, Christopher Smith, P. Quirke, S. Richman, I. Nagtegaal, C. Punt, M. Koopman, T. Bachleitner-Hofmann, I. Simon, J. Tabernero, R. Rosenberg, J. Akker, Y. Li, B. Chan, G. Lanza, A. Glas, M. O’connell, M. Lee, M. Lopatin, G. Yothers, K. Clark-Langone, C. Millward, S. Paik, S. Sharif, S. Shak, N. Wolmark, P. Li, G. Chen, P. Laurent-Puig, G. Manceau, J. Bachet, B. Chibaudel, F. Liébaert, O. Bouché, F. Penault-Llorca, M. Diebold, T. André, S. Imbeaud, V. Heinemann, R. Laubender, D. Modest, A. Jung, L. Weikersthal, U. Vehling‐Kaiser, C. Giessen, T. Kirchner, U. Mansmann, S. Stintzing, A. Custodio, J. Moreno, J. Aparicio, J. Plazas, C. Martos, J. Maurel, D. Ramos, P. Cejas, R. Madero, J. Feliu, A.A.L. Pereira, J. Rêgo, P. Hoff, A. Sasse, R. Riechelmann, E. Mitry, L. Venat-Bouvet, J. Phelip, E. Maillard, J. Jouve, X. Adhoute, D. Gargot, M. Gasmi, L. Bedenne, T. Aparicio, R. Midgley, S. Love, V. Potter, E. Segelov, A. Weaver, C. Scudder, P. Julier, S. Grumett, D. Kerr, S. Ahmed, R. Shahid, A. Leis, K. Haider, P. Pahwa, J. Hardingham, C. Lee, A. Townsend, J. Wrin, A. Weickhardt, C. Munroe, N. Tebbutt, I. Tan, T. Seah, S. Koo, S. Choo, C. Tham, D. Chong, I. Calderero, A. Moya, A. González, A. Carranza, M. Conde, S. Molina-Pinelo, M. Herrera, M. Mirón, P. Garcia, R. García-Carbonero, F. Cappuzzo, A. Sacconi, L. Landi, F. Biagioni, V. Ludovini, E. Sensi, J. Salvini, G. Fontanini, G. Blandino, L. Crinò, A. Garcia, D. Páez, J. Blanco, M. Puyal, M. Martín-Richard, A. Barnadas, M. Baiget, S. Zazo, T. Caldés, N. González, J. Madoz, J. Satre, R. Manso, D. Ferrandez, T. Ramos, J. García-Foncillas, E. Díaz-Rubio, A. Kermani, A. Jafarian, J. Esmaeili, N. Roshan, M. Toosi, A. Ashrafi, M. Shahri, A. Gonçalves, A. Lhoumeau, G. Monges, J. Delpero, J. Raoul, J. Borg, W. Mesker, V. Pelt, H. Gelderblom, V. Krieken, R. Tollenaar, S. Campos-Gómez, V. Camargo, R. Fallas, J. Arredondo, L. Juarez, S. Alvarez, D. Bocanegra, D. Melendez, S. Sadahiro, T. Suzuki, A. Tanaka, K. Okada, A. Kamijo, H. Nagase, J. Uchida, S. Kim, K. Park, S. Shin, K. Lee, T. Kim, N. Kim, S. Rha, J. Roh, J. Ahn, L. Paré, Myung Lee, S. Oh, W. Kang, S. Kim, M. Ortiz-Morales, C. Morales, A. Gomez, G. Pulido, M. Osuna, J. Jimenez, P. Sánchez, M. Medina, J. Rodríguez, E. Aguilar, F. Dane, M. Ozturk, M. Kocar, B. Atasoy, B. Aktas, F. Telli, M. Kanıtez, M. Bes¸irog˘lu, P. Yumuk, S. Turhal, B. Metzger, M. Dicato, G. Mahon, S. Obertin, J. Kayser, J. Foncillas, C. Caramés, G. Serrano, A. León, A. Campos, J. Martin-Valades, C. Cañadas, T. Hernández-Guerrero, F. Rojo, H. Schmoll, J. Maroun, F. Braud, M. Hill, S. Hoersch, K. Rittweger, D. Haller, A. Kumar, H. Kennecke, H. Lim, R. Woods, D. Renouf, C. Speers, W. Cheung, K. Kondo, T. Tsuchiya, K. Sasaki, K. Katsumata, G. Nishimura, Y. Kakeji, H. Baba, S. Kodaira, S. Saji, C. Qvortrup, M. Cvancarova, B. Glimelius, P. Pfeiffer, H. Sorbye, U. Sartorius, M. Schlichting, A. Graser, F. Kabbinavar, H. Hurwitz, B. Giantonio, Z. Guan, L. Mitchell, D. Waterkamp, R. Zhang, Z. Lu, X. Wu, D. Wan, Z. Pan, J. Xu, L. Ye, L. Ren, Y. Wei, J. Douillard, S. Siena, M. Peeters, C. Davison, S. Braun, R. Sidhu, C. Steffens, J. Bennouna, J. Sastre, P. Österlund, R. Moos, I. Reyes-Rivera, M. Sersch, S. Zafar, A. Grothey, T. Bekaii-Saab, J. Bendell, B. Sherrill, L. Bennett, Y. Mun, M. Sersch, D. Dalal, I. Láng, C. Köhne, P. Rougier, D. Curran, E. Hitre, I. Griebsch, L. Heijmen, E. Voert, L. Geus-Oei, A. Heerschap, J. Bussink, V. Zerbi, W. Oyen, O. Boerman, H. Laarhoven, F. Petrelli, K. Borgonovo, M. Cabiddu, M. Ghilardi, M. Cremonesi, F. Maspero, S. Barni, J. Wang, Zhongyun Zhao, B. Barber, J. Zhang, M. Gallagher, J. Prado, C. Borg, R. Greil, E. Cutsem, B. Bendahmane, S. Kubicka, D. Zang, I. Chung, H. Oh, K. Park, K. Lee, B. Han, D. Choi, H. Kim, J. Kim, A. Avallone, E. Gennaro, L. Aloj, P. Delrio, B. Pecori, F. Tatangelo, A. Petrillo, V. Iaffaioli, S. Lastoria, A. Budillon, F. Lévi, V. Boige, M. Hebbar, D. Smith, C. Focan, R. Guimbaud, C. Carvalho, M. Bouchahda, M. Ducreux, A. Deleporte, A. Hendlisz, T. Delaunoit, R. Maréchal, S. Holbrechts, M. Eynde, G. Houbiers, M. Moreau, P. Flamen, J. Douillard, A. Rong, V. Alonso-Orduña, C. Schlichting, B. McCall, J. Metges, J. Ramée, O. Dupuis, P. Deguiral, E. Boucher, O. Cojocarasu, M. Ferec, M. Porneuf, F. Grudé, M. Yoshida, T. Kato, S. Iwamoto, Y. Miyake, M. Nakamura, T. Sato, D. Sakai, M. Matsuoka, T. Otsuji, H. Furukawa, E. Shinozaki, H. Bando, T. Nishina, K. Yamazaki, S. Kadowaki, S. Yuki, S. Kajiura, K. Tsuchihara, S. Fujii, T. Yoshino, S. Kawada, M. Ishiguro, H. Uetake, T. Ishikawa, Y. Kusunoki, F. Kinoshita, N. Kashiwagi, Y. Nagata, Y. Matsubara, K. Sugihara, S. Khays, K. Mamontov, A. Kotelnikov, S. Lazarev, A. Lazarev, M. Gizzi, G. Pairet, P. Lefesvre, V. Lannoy, J. Gigot, B. Navez, J. Canon, C. Sempoux, J. Carrasco, M. Codesido, J. Wilkerson, L. Gayo, M. Alonso, P. Garcia, A. Ochoa, A. Martín, S. Suárez, P. Alfonso, T. Fojo, D. Malka, M. Faron, C. Caramella, P. Rivera, T. Baère, D. Goéré, J. Pignon, R. Lakomy, J. Prausová, P. Ruff, V. Moiseyenko, D. Ferry, E. Boelle, J. Mckendrick, C. Allegra, M. Krebs, S. Gollins, I. Chau, J. Hasan, M. Braun, K. Morris, J. Beech, G. Adaway, C. Dive, M. Saunders, C. Phuan, C. Tan, L. Lee, T. Aung, C. Chua, D. Tai, H. Mansy, C. Garcia, L. Ameye, S. Ohigashi, K. Sudo, H. Onodera, D. Kobayashi, O. Takahashi, T. Takahashi, T. Asahara, K. Nomoto, K. Chan (2012)

    Gastrointestinal tumors, colorectal

    Annals of Oncology, 23

  • J. Baselga, I. Bradbury, H. Eidtmann, S. Cosimo, E. Azambuja, C. Aura, H. Gómez, P. Dinh, K. Fauria, V. Dooren, G. Aktan, A. Goldhirsch, Tsai-Wang Chang, Z. Horváth, M. Coccia-Portugal, J. Dômont, L. Tseng, G. Kunz, J. Sohn, V. Semiglazov, G. Lerzo, M. Pálácova, V. Probachai, L. Pusztai, M. Untch, R. Gelber, M. Piccart-Gebhart (2012)

    Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

    The Lancet, 379

  • A. Cheng, Yoon-Koo Kang, D. Lin, Joong-Won Park, M. Kudo, S. Qin, Masao Omata, S. Lowenthal, S. Lanzalone, Liqiang Yang, M. Lechuga, E. Raymond (2011)

    Phase III trial of sunitinib (Su) versus sorafenib (So) in advanced hepatocellular carcinoma (HCC).

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 15_suppl

  • A. Zhu, O. Rosmorduc, J. Evans, P. Ross, A. Santoro, F. Carrilho, M. Leberre, M. Jensen, G. Meinhardt, Yoon-Koo Kang (2012)

    Search: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients with Hepatocellular Carcinoma (HCC)

    Annals of Oncology, 23

  • L. Paz-Ares, V. Hirsh, Lanjun Zhang, F. Marinis, J.C.-H. Yang, H. Wakelee, T. Seto, T. Schmelter, T. Ong, Tony Mok, E. Smit (2012)

    Monotherapy Administration of Sorafenib in Patients with Non-Small Cell Lung Cancer: Phase III, Randomized, Double-Blind, Placebo-Controlled Mission Trial

    Annals of Oncology, 23

  • A. Zhu, O. Rosmorduc, T. Evans, P. Ross, A. Santoro, F. Carrilho, J. Bruix, S. Qin, P. Thuluvath, J. Llovet, M. Leberre, M. Jensen, G. Meinhardt, Yoon-Koo Kang (2015)

    SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 6

  • D. Ferry, S. Dutton, W. Mansoor, J. Thompson, M. Harrison, H. Abbas, Å. Dahle-Smith, A. Chatterjee, S. Falk, A. Garcia-Alonso, D. Fyfe, R. Hubner, T. Gamble, L. Peachey, M. Davoudianfar, S. Pearson, P. Julier, J. Jankowski, R. Midgely, R. Petty (2012)

    Phase III Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Trial of Gefitinib versus Placebo in Esophageal Cancer Progressing after Chemotherapy, COG (Cancer Oesophagus Gefitinib)

    Annals of Oncology, 23

  • C. Criscitiello, H. Azim, D. Agbor-tarh, E. Azambuja, M. Piccart, J. Baselga, H. Eidtmann, S. Cosimo, I. Bradbury, I. Rubio (2012)

    The Discrepancy Between High Pathological Complete Response (PCR) Rate and Low Breast Conserving Surgery (BCS) Following Neoadjuvant Therapy: Analysis from the Neoaltto Trial (BIG 1-06)

    Annals of Oncology, 23

  • J. Llovet, T. Decaens, J. Raoul, E. Boucher, M. Kudo, Charissa Chang, Yoon-Koo Kang, E. Assenat, Ho Lim, V. Boige, P. Mathurin, L. Fartoux, D. Lin, J. Bruix, R. Poon, M. Sherman, J. Blanc, R. Finn, W. Tak, Y. Chao, R. Ezzeddine, David Liu, I. Walters, Joong-Won Park (2012)

    1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY

    Journal of Hepatology, 56

  • G. Romieu, H. Bonnefoi, J. Pierga, P. Kerbrat, J. Guastalla, A. Lortholary, M. Espié, P. Fumoleau, D. Serin, J. Jacquin, C. Jouannaud, M. Ríos, S. Abadie-Lacourtoisie, N. Tubiana-Mathieu, L. Cany, S. Catala, D. Khayat, I. Pauporté, A. Kramar, M. Piccart, M. Procter, E. Azambuja, H. Weber, M. Untch, I. Smith, L. Gianni, C. Jackisch, D. Cameron, R. Bell, M. Dowsett, R. Gelber, B. Leyland-Jones, J. Baselga (2012)

    ASSOCIATION BETWEEN TUMOR EGFR AND KRAS MUTATION STATUS AND CLINICAL OUTCOMES IN NSCLC PATIENTS RANDOMIZED TO SORAFENIB PLUS BEST SUPPORTIVE CARE ( BSC ) OR BSC ALONE : SUBANALYSIS OF THE PHASE III MISSION TRIAL

  • M. Borad, S. Reddy, N. Bahary, H. Uronis, D. Sigal, A. Cohn, W. Schelman, J. Stephenson, C. Eng, D. Ryan, T. Waddell, J. Reis-Filho, D. Gonzalez-de-Castro, I. Chau, A. Wotherspoon, S. Gupta, C. Saffery, G. Middleton, J. Wadsley, D. Cunningham, J. Ajani, W. Pantigoso, G. Bodoky, V. Moiseyenko, M. Lichinitser, V. Gorbunova, I. Vynnychenko, I. Láng, S. Falcón, B. Daniele, L. Rimassa, C. Porta, I. Borbath, S. Salvagni, J. Laethem, H. Vlierberghe, R. Roemeling, G. Abbadessa, A. Santoro, J. Bronowicki, S. Ye, M. Kudo, J. Marrero, A. Venook, K. Nakajima, R. Lencioni, H. Iwase, M. Shimada, T. Tsuzuki, N. Ryuge, Y. Kida, B. Kato, M. Esaki, Y. Tanaka, N. Urata, Y. Hamai, J. Hihara, M. Emi, Y. Aoki, M. Okada, Y. Ezoe, M. Muto, K. Ueda, Y. Ozaki, I. Aoyama, T. Horimatsu, S. Morita, S. Miyamoto, T. Chiba, Y. Xu, W. Mao, X. Sun, Y. Zheng, Y. Jiang, J. Liu, E. Bria, G. Manzoni, S. Beghelli, A. Tomezzoli, S. Barbi, M. Frizziero, I. Sperduti, S. Bersani, G. Tortora, A. Scarpa, J. Xia, J. Zhao, S. So, K. Pan, W. Wang, X. Li, J. Chen, D. Wang, Y. Kurokawa, N. Matsuura, Y. Kimura, R. Kawabata, S. Adachi, J. Fujita, K. Nishikawa, S. Takiguchi, M. Mori, Y. Doki, M. Baykara, M. Benekli, O. Ekinci, U. Coşkun, E. Eser, O. Polat, U. Demirci, A. Uner, A. Ozet, S. Buyukberber, J. Park, M. Ryu, H. Kim, B. Ryoo, I. Park, Y. Park, S. Oh, J. Yook, B. Kim, Y. Kang, C. Bokemeyer, K. Ridwelski, D. Atanackovic, D. Arnold, E. Wöll, M. Büchler, C. Krüger, C. Schuhmacher, S. Yoshino, A. Tsuburaya, M. Kobayashi, N. Hirabayashi, N. Nagata, Y. Miyashita, J. Sakamoto, N. Fukushima, A. Nashimoto, S. Fushida, Y. Kawachi, S. Kuwabara, N. Musha, M. Vidmar, D. Egamberdiev, M. Djuraev, S. Khudayorov, O. Nematov, A. Babaev, H. Tuyev, N. Silvestris, S. Leo, T. Palma, F. Vita, T. Gamucci, S. Barni, R. Ferrara, C. Mazzara, G. Numico, G. Colucci, J. Wei, B. Liu, L. Yu, Z. Zou, X. Qiang, J. Sánchez, C. Costa, A. Giménez-Capitán, N. Karachaliou, R. Rosell, I. Davidenko, T. Iveson, R. Donehower, S. Tjulandin, A. Deptała, M. Zhu, K. Oliner, S. Dubey, E. Loh, H. Hasegawa, H. Inagaki, S. Akamaru, S. Tokunaga, M. Takagi, S. Tamura, T. Tsujinaka, H. Kawai, N. Boku, Y. Yamada, N. Fuse, H. Yasui, A. Sawaki, W. Koizumi, J. Mizusawa, K. Nakamura, A. Takashima, Lin Shen, R. Xu, Jian-bing Wang, Y. Bai, T. Liu, S. Jiao, J. Xu, Y. Liu, N. Fan, S. Al-Batran, N. Tebbutt, G. Luppi, H. Smith, C. Costantini, W. Cheung, S. Rizvi, T. Sahmoud, S. Yuki, K. Shitara, D. Takahari, M. Nakamura, C. Kondo, T. Tsuda, T. Kii, Y. Tsuji, I. Oze, K. Muro, G. Tomasello, W. Liguigli, S. Lazzarelli, R. Poli, F. Negri, L. Toppo, M. Ratti, M. Brighenti, F. Gerevini, R. Passalacqua, K. Matsuo, A. Ohtsu, A. Carrato, A. Ravaioli, L. Jin, T. Nishina, S. Hironaka, A. Tsuji, K. Suzuki, T. Otsuji, T. Shibata, I. Okamoto, I. Hyodo, H. Ishigami, J. Kitayama, H. Yamaguchi, S. Emoto, Toshiaki Watanabe, C. Gómez-Martín, J. Plaza, E. Valle, F. Valladares, P. Fonseca, A. Salud, A. León, F. Rivera, E. Garralda, F. López-Rios, C. Yoo, D. Koo, I. Unek, T. Akman, I. Oztop, O. Unal, T. Salman, A. Yılmaz, H. Yabusaki, N. Atsushi, A. Matsuki, M. Aizawa, T. Aparicio, M. Svrcek, A. Laforest, A. Zaanan, P. Afchain, E. Mitry, J. Taieb, F. Fiore, J. Gornet, P. Laurent-Puig, A. Parthan, M. Sanon, J. Coombs, K. Ouagari, A. Pousa, L. Paz-Ares, C. Pericay, X. Muro, M. Flor, B. Nagy, L. Gray, S. Ward, M. Raikou, I. Boukovinas, M. Geitona, O. Bouché, A. Cesne, M. Ríos, L. Chaigneau, B. Bui, P. Xavier, J. Blay, M. Raponi, J. Isaacson, H. Hahn, M. Bartosiewicz, A. Magnusson, K. Lin, L. Rolfe, A. Allen, V. Picozzi, I. Trouilloud, A. Dupont-Gossard, P. Artru, T. Lecomte, M. Gauthier, A. Thirot‐Bidault, D. Malka, F. Bonnetain, C. Parlak, O. Guler, U. Selek, O. Ozyılkan, E. Topkan, D. Galun, W. Tröger, M. Reif, A. Schumann, N. Stanković, M. Milic´evic´, V. Vaccaro, B. Saracino, M. Pino, G. Grazi, A. Gelibter, G. Vallati, F. Cognetti, M. Milella, L. Ginocchi, E. Vasile, S. Caponi, M. Lucchesi, C. Caparello, V. Prat, M. Baretti, M. Lencioni, S. Ricci, A. Falcone, L. Marthey, A. Sa-cunha, J. Blanc, A. Cueff, E. François, J. Bachet, R. Coriat, V. Karavasilis, G. Pentheroudakis, J. Sgouros, S. Dimoudis, I. Varthalitis, E. Samantas, G. Fountzilas, O. Rua, E. Arévalo, J. Fusco, E. Álvarez, L. Zubiri, J. González, L. Arbea, F. Pardo, S. Algarra, J. Rodríguez, M. Ogasawara, S. Ota, L. Faloppi, A. Mandolesi, M. Scartozzi, C. Loretelli, M. Bianconi, A. Bittoni, R. Giampieri, M. Prete, I. Bearzi, S. Cascinu, F. Massari, E. Lucchini, J. Cho, J. Lim, Seokjoon Lee, D. Lee, Joon Park, D. Yoon, Y. Min, Y. Shindo, S. Hazama, Y. Inoue, Y. Maeda, M. Iida, N. Suzuki, K. Yoshimura, T. Ueno, M. Oka, M. Reni, E. Giovannetti, S. Cereda, C. Belli, A. Passardi, G. Lucca, L. Ferrari, F. Bergamo, A. Novarino, H. Verheul, C. Desauw, F. Hajbi, K. Ligier, A. Duhamel, F. Richard, C. Rosé, N. Lio, C. Cappelli, A. Sainato, C. Greco, F. Mosca, U. Boggi, M. Gilabert, J. Boher, J. Raoul, O. Turrini, F. Paye, P. Bachellier, J. Delpero, G. Afc, T. Okusaka, S. Ohkawa, H. Isayama, A. Fukutomi, K. Yamaguchi, M. Ikeda, A. Funakoshi, M. Nagase, S. Nakamori, Y. Hamamoto, A. Bahl, R. Kapoor, P. Tomar, A. Singh, R. Gupta, S. Sharma, J. Phelip, V. Vendrely, J. Jouve, F. Subtil, M. Gasmi, P. Michel, D. Smith, J. Seitz, L. Bedenne, B. Chauffert, J. Bridgewater, D. Palmer, R. Gillmore, J. Waters, M. Harrison, J. Valle, H. Wasan, P. Corrie, S. Kaneko, Y. Inaba, F. Kanai, T. Aramaki, T. Yamamoto, T. Tanaka, K. Yamakado, K. Imanaka, Y. Arai, M. Allard, E. Vibert, B. Paule, G. Pelletier, M. Sebagh, C. Guettier, D. Castaing, R. Adam, G. Baroni, S. Minicis, A. Benedetti, M. Salem, N. Jain, S. Taylor, G. Dyson, J. Beebe-Dimmer, I. Le, M. Choi, A. Shields, J. Critchfield, P. Philip (2012)

    Gastrointestinal tumors, non-colorectal

    Annals of Oncology, 23

  • X. Pivot, G. Romieu, H. Bonnefoi, J. Pierga, P. Kerbrat, J. Guastalla, A. Lortholary, M. Espié, P. Fumoleau, D. Serin, J. Jacquin, C. Jouannaud, M. Rios, S. Abadie-Lacourtoisie, N. Tubiana-Mathieu, L. Cany, S. Catala, D. Khayat, I. Pauporté, A. Kramar (2012)

    Phare Trial Results Comparing 6 to 12 Months of Trastuzumab in Adjuvant Early Breast Cancer

    Annals of Oncology, 23

  • C. Zielinski, I. Lang, M. Inbar, Z. Kahán, R. Greil, S. Bešlija, S. Stemmer, B. Kaufman, Ž. Zvirbule, G. Steger, B. Melichar, T. Pieńkowski, D. Sirbu, L. Petruželka, A. Eniu, B. Nisenbaum, M. Dank, R. Anghel, D. Messinger, T. Brodowicz, B. Pistilli, A. Urruticoechea, S. Chan, H. Han, G. Jerusalem, A. Kong, Q. Ru, S. Ruquet, D. Sternberg, C. Saura, R. Dienstmann, F. André, J. Soria, J. Tabernero, F. Braud, R. Cereda, R. Bahleda, A. Hollebecque, A. Delmonte, M. Camboni, X. Chen, G. Ye, C. Zhang, X. Li, K. Shen, B. Ataseven, J. Blohmer, C. Denkert, B. Gerber, J. Heil, T. Kühn, S. Kümmel, M. Rezai, S. Loibl, G. Minckwitz, E. Bria, M. Bonomi, J. Furlanetto, S. Pilotto, L. Carbognin, F. Massari, E. Lucchini, D. Melisi, D. Giannarelli, G. Tortora, J. Haba, S. Morales, C. Crespo, A. Antón, E. Carrasco, B. Aktas, K. Mehta, M. Martín, M. Campone, S. Noguchi, K. Pritchard, H. Rugo, G. Hortobagyi, J. Baselga, A. Panneerselvam, T. Taran, T. Sahmoud, M. Piccart, C. Ng, I. Macpherson, D. Rea, J. Spicer, A. Bowman, A. Jones, M. Dowsett, S. Johnston, N. Dobbs, J. Bono, W. Qi, Y. Yao, Z. Shen, F. Lin, Y. Sun, D. Min, A. He, L. Tang, A. Gennari, D. Amadori, O. Nanni, A. Decensi, P. Conte, M. Puntoni, P. Bruzzi, C. Beauchemin, D. Cooper, M. Lapierre, L. Yelle, J. Lachaine, M. Welslau, V. Diéras, J. Sohn, S. Hurvitz, D. Lalla, L. Fang, E. Guardino, D. Miles, Z. Hamidou, T. Dabakuyo, F. Guillemin, T. Conroy, M. Velten, D. Jolly, M. Mercier, S. Causeret, J. Cuisnier, F. Bonnetain, W. Simons, E. Walter, H. Burris, J. Beck, F. Lebrun, L. Bennett, J. Ricci, S. Radema, P. Souverein, R. Meyboom, F. Ahmadizar, Charlotte Onland-Moret, A. Zee, N. Marinsek, J. Etchberger, R. Degun, G. Benelli, S. Saletan, C. Burudpakdee, D. Bertwistle, M. Brammer, R. Carlton, T. Bramley, A. D’souza, R. Palumbo, G. Bernardo, A. Riccardi, F. Sottotetti, B. Tagliaferri, E. Pozzi, C. Teragni, A. Bernardo, O. Garrone, C. Bighin, F. Vaira, M. Donadio, O. Alabiso, M. Carapezza, E. Baldini, M. Merlano, N. Biglia, P. Pronzato, P. Schmid, P. Turner, M. Howlett, R. Jong, G. Sonke, N. Maass, K. Mansouri, L. Cirri, Peipei Shi, O. Hamid, G. Mariani, G. Faggioni, C. Ghiotto, E. Orvieto, S. Valpione, J. Cortés, S. Swain, I. Kudaba, M. Hauschild, T. Patel, E. Grincuka, N. Masuda, V. Mcnally, J. Visich, L. Manso, R. Pérez-Carrión, J. López-Muñiz, A. Palomo, E. Calvo, R. Llorente, J. Casinello, G. Catalán, C. Llorca, C. Grávalos, O. Trédan, B. You, P. Beuzeboc, D. Coeffic, A. Lortholary, M. Fellous, T. Rouge, L. Arnould, J. Ferrero, D. Cameron, M. Mano, V. Vukovic, F. Teofilovici, R. Bradley, A. Awada, Ying-Zi Bu, R. Dulin, C. Villarreal-Garza, F. Lara, L. Bacon, D. Rivera, A. Salceda, L. Urzua, L. Herrera, C. Aguila, J. Bargallo-Rocha, Jessica Tao, Maurizio Scaltriti, Sara Marlow, M. Elkabets, N. Morse, D. Sgroi, M. Gnant, Yoshinori Ito, D. Martins, B. Sousa, J. Paredes, F. Schmitt, M. Kim, Sung-yul Lee, J. Koo, G. Allegrini, G. Bocci, A. Fontana, A. Camerini, A. Ferro, M. Cazzaniga, V. Casadei, E. Bona, M. Scalese, A. Falcone, M. Saghatchian, C. Lévy, C. Villanueva, J. Fleury, A. Mercier-Blas, H. Simon, C. Maignan, N. Mesnard, É. Antoine, J. Gligorov, E. Alba-Conejo, J. Bines, P. Cortes, D. Doval, Zefei Jiang, U. Freudensprung, G. Mustacchi, S. Bernhard, L. Mansi, V. Nerich, E. Dobi, H. Almotlak, F. Bazán, L. Chaigneau, L. Cals, X. Pivot, C. Twelves, M. Nasim, A. Anthoney, N. Cresti, C. Savulsky, C. Johnston, L. Reyderman, J. Wanders, R. Plummer, T. Evans, N. Avcı, O. Kanat, S. Gokgoz, Ş. Tolunay, U. Topal, E. Çubukçu, F. Olmez, H. Sakr, R. Hamed, A. Anter, T. Yossef, F. Fei, Y. Du, X. Gu, Chinfei Chen, J. Wu, Z. Shao, G. Zucchini, S. Quercia, C. Zamagni, D. Santini, M. Taffurelli, S. Fanti, A. Martoni, H. Rugo, S. Formenti, R. Myerson, C. Diederich, B. O'Connor, A. Matzkowitz, F. Muggia, M. Rodionova, D. Ryabchikov, S. Portnoy, I. Vorotnikov, N. Chkhikvadze, R. Rodríguez, M. Osuna, G. Pulido, I. Porras, P. Sánchez, A. Moreno, J. Jiménez, M. Ortiz-Morales, E. Aguilar, J. Haba, N. Matsubara, H. Mukai, Y. Naito, M. Nezu, K. Itoh, L. Campana, S. Galuppo, C. Falci, L. Corti, A. Brunello, G. Zavagno, C. Rossi, F. Petrelli, M. Cabiddu, K. Borgonovo, M. Ghilardi, F. Maspero, M. Cremonesi, S. Barni, J. Stebbing, D. König, B. Thürlimann, F. Otto, L. Plasswilm, M. Hoefliger, I. Senn-Schönenberger, U. Müller, C. Öhlschlegel, H. Senn, S. Ess, M. Abreu, E. Matos, N. Afonso, D. Pereira, H. Rodrigues, R. Henrique, C. Lopes, L. Holmberg, M. Harries, O. Agbaje, H. Garmo, S. Kabilan, Aliki Taylor, A. Purushotham, J. Kawano, N. Hayashi, A. Yoshida, H. Yagata, H. Yamauchi, C. Oliveira, C. Cardoso-Filho, M. Costa-Gurgel, L. Bossi, C. Lima, G. Lourenço, S. Gangopadhyay, S. Mukhopadhyay, S. Dasgupta, U. Roy, A. Mukhopadhyay, M. Saber, S. Akel, G. Ali, N. Ibrahim, D. Arya, B. Parikh, P. Shah, S. Shukla, K. Patel, A. Anand, S. Talati, S. Shah, A. Patel, B. Parekh, T. Pascual, E. Ciruelos, I. Ghanem, R. Manneh, C. Mendiola, D. Lora, H. Cortés-Funes, J. Zaivelieva, I. Schepotin, O. Zotov, L. Kireeva, T. Kondratova, A. Armengol-Alonso, A. Arance, M. Campayo, X. Gonzalez-Farre, A. García-Herrera, P. Fernandez, X. Caparrós, I. Alonso, B. Farrús, M. Muñoz, A. Chakraborty, Chinmoy Bose, D. Bhattacharyya, J. Basak, Suk-Hwan Kang, Kangseok Kim, B. Devi, D. Lymperatou, I. Papasotiriou, M. Chatziioannou, M. Toloudi, E. Ioannou, R. Hammon, U. Jacob, N. Hembry, A. Kopic, C. Bellido-Ribes, S. González, A. Garcia, V. Obadia, R. Bastús, J. Fernández, A. Aguilar, L. Cirera, M. Kaplan, A. Inal, M. Kuçukoner, Z. Urakçı, F. Ekici, U. Fırat, A. Işıkdoğan, A. Mafodda, A. Prestifilippo, R. Maisano, D. Giuffrida, D. Aricò, D. Azzarello, M. Mare, M. Nardi, S. Arifi, F. Hijri, Z. Benbrahim, Y. Akasbi, S. Elfakir, N. Mellas, A. Melhouf, A. Banani, O. Mesbahi, D. Donat, M. Azzara, M. Mansour, C. Mourad, A. Stravodimou, K. Zaman, I. Voutsadakis, Yunpeng Liu, Sha Shi, X. Qu, Jing Shi, Lingyun Zhang, Luyao Xu, Y. Teng, E. Kontopodis, C. Christophylakis (2012)

    Breast cancer, locally advanced and metastatic

    Annals of Oncology, 23

  • T. Hutson, B. Escudier, E. Esteban, G. Bjarnason, Ho Lim, K. Pittman, P. Senico, A. Niethammer, D. Lu, S. Hariharan, R. Motzer (2012)

    Temsirolimus vs Sorafenib As Second Line Therapy in Metastatic Renal Cell Carcinoma: Results from the Intorsect Trial

    Annals of Oncology, 23

  • F. Lordick, G. Bodoky, H. Chung, G. Kurteva, Y. Kang, S. Oh, P. Salman, H. Goette, H. Melezínková, M. Moehler (2012)

    Cetuximab in Combination with Capecitabine and Cisplatin as First-Line Treatment in Advanced Gastric Cancer: Randomized Controlled Phase III Expand Study

    Annals of Oncology, 23

  • R. Gonzalez, A. Ribas, A. Daud, A. Pavlick, T. Gajewski, I. Puzanov, M. Teng, Iris Chan, N. Choong, G. McArthur (2012)

    Phase IB Study of Vemurafenib in Combination with the Mek Inhibitor, GDC-0973, in Patients (PTS) with Unresectable or Metastatic BRAFV600 Mutated Melanoma (BRIM7)

    Annals of Oncology, 23

  • A. Shaw, Dong-Wan Kim, K. Nakagawa, T. Seto, L. Crinò, M. Ahn, T. Pas, B. Besse, B. Solomon, F. Blackhall, Y. Wu, Michael Thomas, K. O'Byrne, D. Moro-Sibilot, R. Camidge, V. Hirsh, T. Mok, V. Tassell, A. Polli, P. Jänne (2012)

    Phase III Study of Crizotinib Versus Pemetrexed or Docetaxel Chemotherapy in Patients with Advanced Alk-Positive Non-Small Cell Lung Cancer (NSCLC) (Profile 1007)

    Annals of Oncology, 23

  • G. Long, J. Sosman, A. Daud, J. Weber, K. Flaherty, J. Infante, O. Hamid, L. Schuchter, J. Cebon, I. Puzanov, A. Algazi, R. Kudchakar, K. Lewis, W. Hwu, R. Kefford, P. Sun, S. Little, R. Gonzalez, K. Patel, K. Kim (2012)

    Phase II Three-Arm Randomised Study of the Braf Inhibitor (BRAFI) Dabrafenib Alone vs Combination with Mek1/2 Inhibitor (MEKI) Trametinib in Pts with Braf V600 Mutation-Positive Metastatic Melanoma (MM)

    Annals of Oncology, 23

  • R. Motzer, Thomas Hutson, J. Reeves, R. Hawkins, Jun Guo, P. Nathan, M. Staehler, P. Souza, J. Merchan, K. Fife, Jie Jin, Robert Jones, H. Uemura, U. Giorgi, U. Harmenberg, Jin-wan Wang, D. Cella, L. McCann, K. Deen, T. Choueiri (2012)

    Randomized, Open-Label, Phase III Trial Of Pazopanib Versus Sunitinib In First-Line Treatment Of Patients With Metastatic Renal Cell Carcinoma (MRCC): Results of the Comparz Trial

    Annals of Oncology, 23

  • E. Nichols, M. Piccart-Gebhart (2013)

    HERA TRIAL: 2 Years versus 1 Year of Trastuzumab after Adjuvant Chemotherapy in Women with HER2-Positive Early Breast Cancer at 8 Years of Median Follow-Up

    , 12

  • D. Berton-Rigaud, J. Alexandre, M. Provansal, A. Casado, A. Martin, C. Fernandez, C. Kahatt, S. Szyldergemajn, J. Campo, A. Poveda, E. Guerra, I. Ray-Coquard (2012)

    Lurbinectedin (PM01183) Activity in Platinum-Resistant/Refractory Ovarian Cancer Patients. Preliminary Results of an Ongoing Two-Stage Phase II Study

    Annals of Oncology, 23

  • B. Daniele, L. Rimassa, C. Porta, I. Borbath, S. Salvagni, J. Laethem, H. Vlierberghe, R. Roemeling, G. Abbadessa, A. Santoro (2012)

    Met as Prognostic Factor and Therapeutic Target in Pretreated Hepatocellular Carcinoma (HCC): Final Results of a Randomized Controlled Phase 2 Trial (RCT) with Tivantinib (ARQ 197)

    Annals of Oncology, 23

  • S. Alberts, D. Sargent, S. Nair, M. Mahoney, M. Mooney, S. Thibodeau, T. Smyrk, F. Sinicrope, E. Chan, S. Gill, M. Kahlenberg, A. Shields, J. Quesenberry, T. Webb, G. Farr, B. Pockaj, A. Grothey, R. Goldberg (2012)

    Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.

    JAMA, 307 13

  • D. Ryan, S. Reddy, N. Bahary, H. Uronis, D. Sigal, A. Cohn, W. Schelman, J. Stephenson, C. Eng, M. Borad (2013)

    TH-302 plus gemcitabine (G+T) versus gemcitabine (G) in patients with previously untreated advanced pancreatic cancer (PAC).

    Journal of Clinical Oncology, 31

  • First efficacy results from the TURANDOT phase III trial comparing two bevacizumab ( BEV ) - containing regimens as first - line therapy for HER 2 - negative metastatic breast cancer ( MBC )

  • F. Blackhall, S. Peters, K. Kerr, K. O'Byrne, H. Hager, A. Sejda, A. Soltermann, C. Dooms, E. Felip, A. Marchetti, E. Speel, N. Price, S. Savic, J. Jong, M. Martorell, E. Thunnissen, L. Bubendorf, O. Dafni, R. Rosell, R. Stahel (2012)

    Prevalence and Clinical Outcomes for Patients With ALK Gene Rearrangement in Europe: Preliminary Results from the European Thoracic Oncology Platform Lungscape Project

    Annals of Oncology, 23

  • R. Salazar, E. Mini, G. Folprecht, F. Subtil, J. Laethem, J. Thaler, J. Bridgewater, E. Cutsem, C. Lepage, J. Taieb (2012)

    ADJUVANT FOLFOX4 PLUS OR MINUS CETUXIMAB (CMAB) IN PATIENTS (PTS) WITH KRAS MUTANT (MKRAS) RESECTED STAGE III COLON CANCER (CC). RESULTS FROM THE PETACC8 INTERGROUP TRIAL

    Annals of Oncology, 23

  • Tony Mok, L. Paz-Ares, Y-L. Wu, S. Novello, E. Juhasz, O. Aren, Yan Sun, Vera Hirsh, E. Smit, C. Lathia, T. Ong, C. Peña, X. Pivot, G. Romieu, H. Bonnefoi, J. Pierga, P. Kerbrat, Jean-Pierre Guastalla, A. Lortholary, M. Espié, P. Fumoleau, D. Serin, J-P. Jacquin, C. Jouannaud, M. Rios, S. Abadie-Lacourtoisie, N. Tubiana-Mathieu, L. Cany, S. Catala, D. Khayat, I. Pauporté, A. Kramar, A. Goldhirsch, M. Piccart, M. Procter, E. Azambuja, H. Weber, M. Untch, I. Smith, Luca Gianni, C. Jackisch, D. Cameron, Richard Bell, M. Dowsett, R. Gelber, B. Leyland-Jones, J. Baselga, Michael Baum, J. Vaidya, Max Bulsara, F. Wenz, Jeffrey Tobias, W. Eiermann, D. Joseph, J. Pierga, B. Asselain, S. Alsafadi, Etienne Brain, F. Lerebours, S. Delaloge, D. Gentien, N. Servant, B. Sigal‐Zafrani, Fabrice Andre, C. Criscitiello, H. Azim, D. Agbor-tarh, H. Eidtmann, S. Cosimo, I. Bradbury, I. Rubio, V. Semiglazov, B. Żurawski, R. Allerton, A. Fabi, E. Ciruelos, R. Parikh, M. Desilvio, S. Santillana, R. Swaby, S. Verma, David Miles, I. Krop, M. Welslau, M. Pegram, D. Oh, Véronique Diéras, E. Guardino, L. Fang, Michael Lu, S. Olsen, Kimberly Blackwell, T. Bachelot, M. Campone, M. Ballester, F. Commo, A. Gonçalves, C. Levy, J. Ferrero, L. Lacroix, F. Dalenc, M. Lacroix, Q. Wang, J. Adélaide, M. Jimenez, C. Heery, N. Ibrahim, R. Madan, M. Mohebtash, P. Arlen, S. McMahon, S. Hodge, S. Steinberg, J. Schlom, J. Gulley, B. Chauffert, L. Feuvret, F. Bonnetain, L. Taillandier, D. Frappaz, J. Honnorat, M. Fabbro, M. Frénay, X. Durando, I. Tennevet, J. Guillamo, H. Tailla, R. Schott, F. Ghiringhelli, C. Campello, C. Dalban, J. Skrzypski, O. Chinot, E. Tabouret, F. Boudouresque, M. Barrié, M. Matta, C. Boucard, A. Loundou, M. Ouafik, Y. Xu, M. Cardoso, M. Palumbo, O. Ishibashi, H. Oltean, K. Kumari, Petr Kavan, A. James, P. Mulholland, S. Peoples, O. Al-Salihi, Chris Twelves, S. Jefferies, S. Halford, J. Ritchie, H. Singh-Jasuja, R. Rampling, J. Taieb, J. Tabernero, Enrico Mini, F. Subtil, G. Folprecht, J. Laethem, J. Thaler, J. Bridgewater, E. Cutsem, P. Rougier, Laurence Collette, M. Praet, M. Schneider, O. Bouché, C. Lepage, C. Girault, J. Emile, P. Laurent-Puig, L. Bedenne, G. Masi, F. Loupakis, L. Salvatore, C. Cremolini, L. Fornaro, M. Schirripa, E. Fea, C. Granetto, L. Antonuzzo, E. Giommoni, G. Allegrini, S. Cupini, C. Boni, M. Banzi, S. Chiara, C. Sonaglio, C. Valsuani, A. Bonetti, L. Boni, A. Falcone, A. Grothey, A. Sobrero, S. Siena, M. Ychou, Yves Humblet, L. Mineur, C. Barone, A. Adenis, T. Yoshino, H. Lenz, Richard Goldberg, D. Sargent, F. Cihon, L. Cupit, A. Wagner, Dirk Laurent, Andrew Zhu, O. Rosmorduc, J. Evans, P. Ross, A. Santoro, F. Carrilho, M. Leberre, M. Jensen, G. Meinhardt, Yoon-Koo Kang, F. Lordick, G. Bodoky, Hyun Chung, G. Kurteva, Sangnam Oh, P. Salman, H. Goette, H. Melezínková, M. Moehler, Kensaku Yoshida, Masashi Fujii, Wasaburou Koizumi, H. Kim, Yun-Jae Kim, M. Takeuchi, T. Nakajima, David Ferry, Susan Dutton, W. Mansoor, J. Thompson, M. Harrison, H. Abbas, Å. Dahle-Smith, A. Chatterjee, S. Falk, A. Garcia-Alonso, D. Fyfe, R. Hubner, T. Gamble, L. Peachey, M. Davoudianfar, S. Pearson, P. Julier, Janusz Jankowski, R. Midgely, Russell Petty, R. Motzer, T. Hutson, J. Reeves, Robert Hawkins, Jun Guo, P. Nathan, M. Staehler, P. Souza, J. Merchan, K. Fife, J. Jin, Robert Jones, H. Uemura, U. Giorgi, U. Harmenberg, J. Wang, David Cella, L. McCann, K. Deen, T. Choueiri, B. Rini, J. Bellmunt, J. Clancy, K. Wang, A. Niethammer, B. Escudier, T. Hutson, E. Esteban, G. Bjarnason, H. Lim, K. Pittman, P. Senico, D. Lu, S. Hariharan, R. Motzer, D. Hidalgo, D. Brewer, G. Attard, D. Danila, J. Clark, C. Parker, Elena Castro, M. Fleischer, Alison Reid, Shahneen Sandhu, R. Jones, C. Cooper, Howard Scher, J. Bono, D. Petrylak, Karim Fizazi, C. Sternberg, N. Budnik, R. Wit, P. Wiechno, D. Barton, A. Fandi, U. Jungnelius, S. Li, N. Vogelzang, C. Massard, Nicholas James, S. Culine, A. Vuorela, M. Mustonen, A. Poveda, F. Selle, F. Hilpert, A. Reuss, A. Pašić, A. Savarese, I. Vergote, P. Witteveen, A. Bamias, D. Bollag, E. Pujade-Lauraine, D. Berton-Rigaud, J. Alexandre, M. Provansal, A. Casado, A. Martín, C. Fernandez, C. Kahatt, S. Szyldergemajn, J. Campo, E. Guerra, I. Ray-Coquard, J. Balmaña, N. Bosch, N. Gadea, C. Heredia, T. Olive, D. Valcárcel, M. Munill, C. Centeno, J. Quesada, J. Surrallés, Georgina Long, J. Sosman, A. Daud, J. Weber, K. Flaherty, J. Infante, O. Hamid, Lynn Schuchter, Jonathan Cebon, I. Puzanov, A. Algazi, R. Kudchakar, Karl Lewis, W. Hwu, R. Kefford, Peng Sun, S. Little, Rene Gonzalez, K. Patel, K. Kim, A. Ribas, A. Daud, A. Pavlick, Thomas Gajewski, M.S.L. Teng, I. Chan, Nicholas Choong, G. McArthur, I. Spanggaard, M. Snoj, A. Cavalcanti, C. Bouquet, G. Sersa, Caroline Robert, B. Vasseur, P. Attali, L. Mir, Julie Gehl, A. Shaw, Dong-Wan Kim, K. Nakagawa, T. Seto, L. Crinò, Marcello Ahn, T. Pas, Benjamin Besse, B. Solomon, F. Blackhall, Yi-Long Wu, Michael Thomas, Kenneth O'Byrne, D. Moro-Sibilot, R. Camidge, V. Tassell, A. Polli, P. Jänne, J. Aerts, H. Codrington, S. Burgers, B. Biesma, O. Dalesio, A.-M.C. Dingemans, A. Vincent, H. Groen, L. Schwartzberg, K. Tauer, J. Atkins, K. Sivarajan, V. Patel, B. Bastos, C. Langer, M. Socinski, D. Spigel, R. Rosell, B. Sureda, C. Costa, M. Molina, A. Giménez-Capitán, N. Karachaliou, J. Wei, A. Vergnenegre, P. Giannikopoulos, C. Mermel, T. Bivona, F. Marinis, E. Felip, T. Bueno, R. Gervais, M. Santarpia, M. Majem, J. Bosch-Barrera, M. García-Campelo, L. Zhang, J.C.-H. Yang, H. Wakelee, T. Schmelter, Suresh Ramalingam, Jeffrey Crawford, A. Chang, C. Manegold, Roman Perez-Soler, J. Douillard, N. Thatcher, F. Barlesi, T. Owonikoko, Y. Wang, P. Pultar, J. Zhu, R. Malik, G. Giaccone, B. Zaric, G. Goss, V. Vukovic, I. El‐Hariry, F. Teofilovici, A. Enke, D. Fennell, N. Kuderer, H. Wang, J. Mehta, L. Eckert, Ahmed Hamed, R. Luengo-Fernandez, J. Leal, Richard Sullivan, A. Mori, A. Goren, I. Gilloteau, M. DiBonaventura, A. Klatsky, Yan Li, David Baer, M. Armstrong, N. Udaltsova, G. Friedman, S. Cushen, A. Ryan, L. Burns, U. Kenny, D. Power, Ian Judson, Jaap Verweij, H. Gelderblom, J. Hartmann, P. Schöffski (2012)

    Breast cancer, early stage

    Annals of Oncology, 23

  • Kensaku Yoshida, M. Fujii, W. Koizumi, H. Kim, Young-geun Kim, M. Takeuchi, T. Nakajima (2012)

    S-1 Plus Docetaxel Versus S-1 for Advanced Gastric Cancer (START TRIAL) Update 2012 (JACCRO AND KCSG STUDY GROUP)

    Annals of Oncology, 23

  • B. Rini, J. Bellmunt, J. Clancy, K. Wang, A. Niethammer, B. Escudier (2012)

    Randomized Phase IIIB Trial of Temsirolimus and Bevacizumab Versus Interferon and Bevacizumab in Metastatic Renal Cell Carcinoma: Results from Intoract

    Annals of Oncology, 23

Publisher
SAGE
Copyright
Copyright © 2020 by SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
ISSN
1758-8359
eISSN
1758-8359
DOI
10.1177/1758834012467829
Publisher site
See Article on Publisher Site

Abstract

467829 TAM511758834012467829Therapeutic Advances in Medical OncologyG Mallarkey and RC Coombes Therapeutic Advances in Medical Oncology Editorial Ther Adv Med Oncol Targeted therapies in medical oncology: (2013) 5(1) 5 –16 DOI: 10.1177/ successes, failures and next steps 1758834012467829 © The Author(s), 2012. Reprints and permissions: Gordon Mallarkey and R. Charles Coombes http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: The move towards personalized medicine is France) have tested the entire genome of individ- Gordon Mallarkey, ongoing with exciting research being conducted ual breast cancers in an attempt to better personal- PhD, MRPharmS Sage Publications Ltd, 1 across all areas of oncology. The evidence pre- ize treatment. It may be that whole-genome testing Oliver’s Yard, 55 City Road, sented at the 2012 European Society of Medical can identify both frequent and rare unexpected London, EC1Y 1SP, UK mallarkey@sagepub.co.uk Oncology Congress (Vienna, 28 September–2 genomic events, quantify genomic instability, and Prof. R. Charles Coombes October 2012) adds to the move towards select- detect the driver mutations causing genomic alter- Division of Cancer, ing patients for specific drug treatments based on ations that lead to resistance to targeted agents. Imperial College, Hammersmith Hospital elucidating biomarkers that reveal susceptible Campus, London, UK mutations or pathways. Epidermal growth factor

Journal

Therapeutic Advances in Medical OncologySAGE

Published: Jan 3, 2013

There are no references for this article.